Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL6323261

CSc1ccc([S+](C)C)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.37
MAPK1 P28482 1/20 0.37
TSHR P16473 2/20 0.37
GPR3 P46089 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
ALOX12 P18054 1/20 0.35
GAA P10253 1/20 0.35
PTGS2 P35354 4/20 0.34
PTGS1 P23219 2/20 0.34
ESR1 P03372 1/20 0.34
LMNA P02545 2/20 0.33
ALOX15 P16050 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL74504 0.84 ALDH1A1 (0.39) ALDH1A1MAPK1TSHRGPR3SMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL3139918 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1TSHRGPR3SMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL562050 0.80 GPR3 (0.43) ALDH1A1GPR3SMN1; SMN2KMT2AMEN1
Trifluoromethanesulfonic Acid SCHEMBL4182001 0.79 KCNH2 (0.43) ALDH1A1GPR3GAAESR1LMNA
Trifluoromethanesulfonic Acid SCHEMBL30536270 0.79 ACHE (0.43) ALDH1A1GPR3KMT2AMEN1PTGS2
Trifluoromethanesulfonic Acid SCHEMBL36457 0.78 GPR3 (0.47) GPR3
Trifluoromethanesulfonic Acid SCHEMBL30925713 0.77 ENPP2 (0.44) GPR3KMT2AGAAESR1LMNA
Trifluoromethanesulfonic Acid SCHEMBL30536277 0.77 ALDH1A1 (0.44) ALDH1A1MAPK1TSHRGPR3SMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL5146818 0.76 KCNH2 (0.46) KMT2AGAA
Trifluoromethanesulfonic Acid SCHEMBL30417272 0.76 PTGS2 (0.38) ALDH1A1MAPK1GPR3PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050258398-A1 Dithia-s-indacene derivative TAKASAGO INTERNATIONAL CORPORATION 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050258398-A1 Dithia-s-indacene derivative DDB1, XDH, TXNL1 ALDH1A1 1916/4885MAPK1 687/4885TSHR 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.